Vigabatrin Powder, For Solution
Product Images NDC 49884-358

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 49884-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 1)

Chemical structure diagram of vigabatrin showing its molecular composition and connectivity, including an amino group, vinyl group, and carboxylic acid group.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 10)

An instructional image showing a hand holding an oral syringe filled with liquid to the 10 mL line. The syringe is marked with measurement lines and numbers for accurate dosing.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 11)

An instructional illustration showing a hand holding an oral dosing syringe above an empty glass. The syringe is marked with volume measurements and is positioned as if about to dispense or retrieve liquid into or from the glass, likely demonstrating preparation or administration of the oral solution.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 12)

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 13)

Illustration showing a close-up of hands holding an oral dosing syringe being placed into an empty clear glass. The graduated syringe is marked in milliliters from 1 to 10 mL, commonly used for precise oral liquid medication measurement and administration.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 14)

An illustration showing a close-up of a hand holding an oral syringe with measurement markings up to 5 mL, commonly used for administering liquid medication dosed orally.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 15)

Black and white illustration showing an adult hand administering oral medication to a baby using a marked oral syringe placed in the baby's mouth.*

FDA Label Image

Pouch Label Front Side (Vigabatrin For Oral Solution 16)

Label for Vigabatrin for Oral Solution, USP 500 mg packet. The front side shows directions to mix each packet with 10 mL of water before administration and includes storage instructions to keep at 20° to 25°C. The labeler is Par Pharmaceutical. The back side includes distribution and manufacturing information, with Par Pharmaceutical as distributor and Par Formulations Private Limited in India as manufacturer.*

FDA Label Image

Pouch Label Back Side (Vigabatrin For Oral Solution 17)

Packaging label for Vigabatrin for Oral Solution, USP, 500 mg per packet, in a box containing 50 packets. The label includes instructions to mix each packet with 10 mL of water before administration. Labeled by Par Pharmaceutical and manufactured by Par Formulations Private Limited, India. The label also features storage instructions and a barcode.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 2)

A cumulative frequency plot showing % reduction in seizure frequency on the y-axis and % of patients on the x-axis for vigabatrin (VGB) at doses 1g/day, 3g/day, 6g/day, and placebo. Separate curves represent each treatment group with corresponding legends. The vertical axis indicates improvement and worsening relative to no change in seizure frequency.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 3)

A cumulative distribution plot comparing seizure frequency reduction between placebo and 3g/day vigabatrin (VGB) groups. The x-axis represents the percentage of patients, while the y-axis shows the percentage reduction in seizure frequency, ranging from -100% (worsening) to 100% (improvement). Two lines indicate patient response distributions for each treatment.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 4)

The image shows a vial label for VIGABATRIN oral solution, USP 50 mg/mL, a human prescription drug by Par Health USA, LLC. The label includes dosage instructions and preparation details. The image also shows two oral syringes, a drinking glass with a spoon, and a pair of scissors, indicating preparation for oral administration.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 5)

An illustrated diagram of an oral syringe labeled to indicate parts including the tip, dosage indicators on the barrel, the barrel itself, the bottom of the white plunger, and the plunger. The syringe is intended for measuring liquid medication, consistent with administration of the powder for solution oral dosage form of vigabatrin.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 6)

An image showing a hand pouring the contents of a small single-dose powder packet into a clear drinking glass, presumably to prepare an oral solution from the powder. The packet contains a white powder intended for oral solution preparation.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 7)

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 8)

An illustration showing a person holding and submerging an oral powder for solution dose-measuring tube into a glass of water. The tube has volume markings to measure liquid, demonstrating preparation of an oral solution dose, likely representing the use of Vigabatrin powder for solution 50 mg/mL by Par Health USA, LLC.*

FDA Label Image

Vigabatrin (Vigabatrin For Oral Solution 9)

The image shows a hand holding an oral dosing syringe filled with liquid medication. The syringe has clear measurement markings in milliliters (mL) on its transparent barrel. The medication inside appears to be a clear liquid. This syringe is used for precise oral dosing, consistent with liquid oral products like VIGABATRIN powder for solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.